BY SIMONE J. SMITH
Abortion is a highly emotional subject and one that excites deeply held opinions. Equitable access to safe abortion services is first and foremost a human right, and I want to point out a keyword in the above sentence SAFE!
I was disturbed by an email forwarded to be from CitizenGo about a 19-year-old girl who died in Canada due to the abortion pill Mifegymiso (also known as RU-486).
It is safe to say that she would be alive today if Health Canada had not approved the chemical abortion pill as “SAFE” in 2015. Mifegymiso is designed to kill preborn babies, and also has known deadly risks to the mother’s life.
This 19-year-old girl died on July 4th, 2022. Her death was first reported to the Government of Canada’s public database that tracks adverse reactions to drugs. The report shows that, on July 4th, 2022, a hospital reported that a 19-year-old female used the abortion drug Mifegymiso and died of “septic shock,” a known risk of the drug.
The tragic news came as abortion activists pushed to expand the abortion drug mifepristone across the U.S. and Canada, claiming it’s “Safer than Tylenol.” In actuality, the drug has been linked to the deaths of millions of unborn babies and dozens of mothers.
This is not the first death of a woman in Canada from the abortion pill. In 2001, a 26-year-old woman died during a clinical trial of the drug, and the trials were halted as a result. Despite this, Health Canada went on to APPROVE Mifegymiso for its “SAFETY, efficacy, and quality.”
The medication started to become available to the public in January 2017. Mifepristone is an anti-hormone used to end a pregnancy. The Mifepristone and Misoprostol regimen is on the World Health Organization’s list of essential drugs. It is considered the “gold standard” for medical abortion.
Mifepristone is already available in 60 countries. Its use has been approved in France and in China since 1988 (almost 30 years ago) and the claim is that it has maintained an outstanding safety record throughout the world. In many countries, it is used safely up to 10 weeks of pregnancy and beyond. Just like surgical abortion, trained providers offer the procedure under high quality conditions, which highly diminish the risk of possible complications.
In Canada, Mifegymiso can currently be prescribed up to nine weeks gestation for on-label use. Physicians can prescribe it off-label up to 10 weeks of gestation as it has been used safely and effectively up to that gestational age and beyond.
CitizenGO feels strongly that BANNING Mifegymiso in Canada will save women’s lives and the lives of their preborn children. How many more lives will this drug claim before Health Canada decides that it is time to act? Although abortion activists claim the drug is extremely safe for women, reports of women’s deaths, data and studies show the opposite to be true. Even the Health Canada government website warns women that the abortion drug has serious risks, including death.
CitizenGO is partnering with Campaign Life Coalition (CLC) to demand that Health Canada bans Mifegymiso. They need your voice to pressure Health Canada and Health Minister Jean-Yves Duclos to take action in protecting the health and well-being of Canadian women and their preborn children.
With your help, we can pressure Health Canada to act now to protect maternal and infant health and prevent further tragedies.